CASP3 and breast cancer: Based on recent research, rGO could induce apoptosis in breast cancer cells by mitochondrial membrane potential reduction, deregulation of mitochondrial proteins, activation of caspase-9 and caspase-3, cell cycle arrest, and deregulated P21 expression (Figure 6).